References
- Nesland Aa, Berstad A. Erosive prepyloric changes in persons with and without dyspepsia. Scand J Gastroenterol 1985; 20: 222–228
- Anonymous. Management of dyspepsia. Report of a working party. Lancet 1988; 1: 576–579
- Nesland Aa, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985; 20: 629–635
- Weberg R, Berstad A. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial. Scand J Gastroenterol 1988; 23: 237–243
- Nagashima R. Mechanisms of action of sucralfate. J Clin Gastroenterol 1981; 3(suppl 2)117–127
- Brogden R N, Heel R C, Speight T M, Avery G S. Sucralfate: a review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs 1984; 27: 194–209
- Karvonen A-L, Lehtola J. Outcome of gastric mucosal erosions. A follow-up study of elective gastroscopic patients. Scand J Gastroenterol 1984; 19: 228–234
- Kairalouma M I, Hentilae R, Alavaikko M, et al. Sucralfate versus placebo in treatment of non-ulcer dyspepsia. Am J Med 1987; 83(suppl 3B)51–55
- Nørrelund N, Helles Aa, Schmiegelow M, et al. Uncharacteristic dyspepsia in general practice. A controlled trial with aluminium aminoacetate + magnesium hydroxide (Alminox). Ugeskr Laeger 1980; 142: 1750–1753
- Kelbæ H, Linde J, Eriksen J, Munkgaard S, Moes-Gaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 281–287